Sep 11, 2026 by James HalleyI Almost Didn't Buy This 6%+ Yielder Because of Industry Headwinds. Here's Why I'm Glad I Bought It Anyway.Franklin Templeton has delivered a total return of more than 88% since January 2020.
Sep 10, 2026 by James HalleyInstitutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You?Madrigal has a first-mover advantage in treating MASH, a type of fatty liver disease.
Sep 9, 2026 by James HalleyWall Street Sees a Multibillion-Dollar Humanoid Robot Market. These 2 Suppliers Get Paid Either Way.Hesai Group is dominant in lidar sensors, and Parker-Hannifin is a provider of key components.
Sep 9, 2026 by James HalleyNuScale Stock vs. Oklo Stock: Wall Street Says Buy One and Sell the Other.Despite its tumble this year, analysts see a brighter future for Oklo than for NuScale.
Sep 8, 2026 by James HalleyMove Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right NowPfizer's 6% dividend yield is enticing, but AbbVie's dividend growth is superior.
Sep 7, 2026 by James HalleyBetter Space Stock: AST SpaceMobile vs. L3Harris TechnologiesAST SpaceMobile's shares have come back to Earth. Is it now a better buy than L3Harris Technologies?
Sep 6, 2026 by James HalleyBWX Technologies Already Builds Reactors for the Navy. Why Is It Still the Cheapest Nuclear Stock?BWX Technologies is trading at a discount compared to its peers despite its military moat.
Sep 5, 2026 by James HalleyPrediction: Here's What a $5,000 Investment in Eli Lilly Could Look Like in 5 YearsEli Lilly's total return topped 367% over the past five years, largely thanks to enthusiasm for its GLP-1 offerings.
Sep 5, 2026 by James HalleyGilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?Gilead Sciences is branching out beyond its HIV franchise into oncology and immunology therapies.
Sep 3, 2026 by James HalleyBetter Drone Stock: Kratos Defense vs. Northrop GrummanKratos Defense and Security Solutions and Northrop Grumman are two great ways to play the trend toward increased military drone spending.
Sep 2, 2026 by James Halley2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right NowIf you're looking to invest $1,000 in a dividend stock, look to the pharmaceutical sector.
Sep 2, 2026 by James HalleyBetter Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands?The Canadian cannabis companies are both seeing strong growth, but one is a better buy right now.
Aug 31, 2026 by James HalleyGreen Thumb Industries Stock Looks Stuck. Here's Why Wall Street Loves the Cannabis Stock Anyway.Green Thumb's shares are down more than 5% this year, yet analysts have a price target more than double the stock's current price.
Aug 29, 2026 by James HalleyWall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors ThinkThe healthcare giant's shares have pulled back more than 12% over the past month.
Aug 28, 2026 by James HalleyOracle's Data Center Spending Is Exploding. Here's the Power Stock That Actually Benefits.Oracle's data centers need power, and Bloom Energy's fuel cells are delivering it.
Aug 28, 2026 by James HalleyWarren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets.Johnson & Johnson and Merck are healthcare giants with dependable returns that weather economic downturns well.
Aug 28, 2026 by James Halley1 Reason I Passed on Oklo Even After Its Big RallyOklo's stock surged more than 12% on Aug. 25. I'm still staying away.
Aug 27, 2026 by James HalleyMP Materials vs. Enterprise Products: Which "Boring" Business Actually Has the Better Growth Case?The companies are not that much alike, but they're both showing strong revenue and earnings growth.
Aug 27, 2026 by James HalleyThis Earnings Season Confirmed the AI Power Bottleneck Is Real. Here Are the Industrial Winners Hiding in Plain Sight.These three industrial stocks are quietly benefiting from the AI boom.
Aug 26, 2026 by James HalleyConstellation's New Power Deals Are Piling Up. Here's Why the Stock Isn't Reflecting It Yet.Constellation keeps racking up the deals, but its stock is trading more than 51% below its 52-week high.
